Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing
Abstract Transcriptome profiling is a mainstay of translational cancer research and is increasingly finding its way into precision oncology. While bulk RNA sequencing (RNA-seq) is widely available, high investment costs and long data return time are limiting factors for clinical applications. We inv...
Main Authors: | Andreas Mock, Melissa Braun, Claudia Scholl, Stefan Fröhling, Cihan Erkut |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-29550-8 |
Similar Items
-
Improved Nanopore full-length cDNA sequencing by PCR-suppression
by: Anthony Bayega, et al.
Published: (2022-10-01) -
Assessing the utility of the Oxford Nanopore MinION for snake venom gland cDNA sequencing
by: Adam D. Hargreaves, et al.
Published: (2015-11-01) -
Applications of Nanopore sequencing in precision cancer medicine
by: Dyshlovoy, SA, et al.
Published: (2024) -
Analysis of Fowl Adenovirus 4 Transcriptome by De Novo ORF Prediction Based on Corrected Nanopore Full-Length cDNA Sequencing Data
by: Zhuozhuang Lu, et al.
Published: (2023-02-01) -
Quantitative analysis of C. elegans transcripts by Nanopore direct-cDNA sequencing reveals terminal hairpins in non trans-spliced mRNAs
by: Florian Bernard, et al.
Published: (2023-03-01)